TFE3 and neoplasm with perivascular epithelioid cell differentiation: In addition, a gene rearrangement affecting transcription factor binding to IGHM enhancer 3 (TFE3) has been reported in a small subset of patients with PEComa (approximately 23% of cases) [11, 20].